Ernst P, Rinke J, Franke GN, Dicker F, et al. Treatment-free remission after third-line therapy with asciminib in chronic myeloid leukemia with an atypical e19a2 BCR::ABL1 transcript and T315I mutation. Leukemia 2024 Jul 4. doi: 10.1038/s41375-024-02327.
PMID: 38965368